Quarterly Reviews and an Unapproved Formulary Switch in a Nursing Facility
A long-term-care pharmacy serves a 120-bed skilled nursing facility. The consultant pharmacist visits quarterly and performs drug regimen review then. The facility keeps an emergency kit containing oxycodone 5 mg tablets and lorazepam 1 mg tablets. On review, the pharmacist finds a resident who has taken omeprazole 20 mg daily for two years; the pharmacy's formulary now prefers pantoprazole. Another resident has a PRN lorazepam order written eight months ago, with no gradual dose reduction and no current prescriber review; the nurse says the medical director 'said it's fine.' The facility asks the pharmacist to switch the omeprazole to pantoprazole today and to restock the emergency kit.
1. Is quarterly drug regimen review acceptable? What must the pharmacist do with the findings?
Read the worked answer
No. Drug regimen review in a skilled nursing facility must be performed at least monthly.
- Federal nursing facility requirements call for a consultant pharmacist to review each resident's drug regimen at least monthly, with the goal of identifying unnecessary drugs, adverse consequences, and irregularities.
- Quarterly review is a deficiency. The pharmacist should establish a monthly schedule, document each review, and report irregularities to the attending physician and the medical director.
- The pharmacist should document the recommendations and the response. If the facility fails to act on significant irregularities, the pharmacist should escalate through the medical director and, if necessary, the state survey agency.
- The pharmacist's role is advisory but carries a documented duty; a paper review without follow-up does not satisfy the standard.
2. May the pharmacist switch the resident from omeprazole to pantoprazole today without contacting the prescriber?
Read the worked answer
No. A formulary preference is not authority to therapeutically interchange.
- Generic substitution of a therapeutically equivalent product is different from therapeutic interchange. Switching between different active moieties requires prescriber authorization unless a valid facility protocol or pharmacy and therapeutics process specifically authorizes it and the prescriber has agreed.
- The pharmacist should contact the prescriber, explain the formulary change, and obtain an order if the prescriber agrees. The conversation and the new order should be documented.
- If the prescriber does not respond, the resident should remain on the existing order. The pharmacist may not change therapy based on cost or formulary alone.
- The same principle applies to other residents in the facility; a blanket practice of unapproved interchange would be a system-wide compliance problem.
3. What are the requirements for the controlled substances in the emergency kit, and how should the eight-month-old PRN lorazepam order be handled?
Read the worked answer
The emergency kit must be pharmacy-controlled, locked, limited, and documented, and the lorazepam order requires prescriber review.
- Controlled substances in a facility emergency kit must be stored securely under lock, limited to a defined list and quantity, and accessible only through a documented process. Use requires a valid order for the resident; replacement requires a prescription or appropriate authorization, and the pharmacy must maintain records of removal and replacement.
- An eight-month-old PRN lorazepam order is a red flag. Federal law limits Schedule III–V prescriptions to five refills and six months from the date of issue, and a PRN order of this duration requires prescriber review. For a psychotropic drug in a nursing facility, a gradual dose reduction should be considered and documented unless clinically contraindicated.
- A nurse's report that the medical director 'said it's fine' is not a substitute for a current order. The pharmacist should contact the prescriber, obtain a documented decision, and note the recommendation.
- If the order is expired or the prescriber cannot be reached, the pharmacist should not permit continued routine use without appropriate authorization.